Novartis acquires Selexys Pharmaceuticals

25-11-2016

Novartis acquires Selexys Pharmaceuticals

maradon 333 / shutterstock.com

Novartis has acquired Selexys Pharmaceuticals Corporation, a company specialising in the development of therapeutics in certain hematologic and inflammatory disorders.


Novartis, Selexys Pharmaceuticals, m&a, SelG1, sickle cell disease

LSIPR